AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 161 min read$TER

Smith Gregory Stephen sold $1.4M of TER

Smith Gregory Stephen (President and CEO) sold 4,000 shares of TERADYNE, INC (TER) at $337.83 ($1.35M total) on 2026-09-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Smith Gregory Stephen
Published Sep 16, 2026, 4:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 4:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$TER
Bearish
medium confidence
Mentioned
$TER
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERBearishLow
01

Why it matters

The disclosed sale reduces the CEO's ownership, which may be interpreted as a negative signal, but the pre-arranged 10b5-1 plan tempers speculation.

02

Market read

The filing provides fresh insider activity data, offering a modest trading cue for TER.

03

What to watch

Potential upcoming earnings or strategic announcements could contextualize the sale.

Relevance 5/10Novelty 7/10Timing: post-market 2026-09-15

Background

Form 4 filings disclose insider transactions; a CEO sale often draws investor attention.

Company-level read

Ticker impact

$TERBearishMedium confidence
Context

CEO Stephen Smith sold 4,000 shares for $1.35M via a 10b5-1 plan, reducing his stake to 108,495 shares.

Expected impact

Possible modest downside pressure in the near term.

Evidence & confidence

The sale size is material for a mid-cap and executed under a pre-arranged plan, suggesting a neutral to slightly negative market reaction.

Market effects

Sector

Minimal impact on the broader medical device sector.

Regional

Limited to U.S. investors tracking insider activity.

Global

Low

Counterpoint

What could challenge this read

The sale may be purely liquidity-driven, not indicative of company outlook.

Key entities

  • Executive
    Stephen Smith

    President and CEO of Teradyne, Inc.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

TER insider trading history →

Related articles

OCT 12
$FORMHighAI 8/10

FormFactor and Teradyne announce collaboration, $300M investment

FormFactor (FORM) and Teradyne (TER) announced a collaboration and $300M investment in semiconductor test and measurement technologies. The deal aims to combine FormFactor's probe technologies with Teradyne's automated test platforms, focusing on high-performance compute and advanced packaging applications. The transaction is subject to regulatory approvals.

investing.com2 min